16% of all Cubans living in America in 1990 arrived during the Mariel Boatlift. 8% of all Cuban-Americans (that were in the country in 1990) arrived in the single month of May 1980.
On the Impossible: Why Cassava Sciences’ simufilam will fail Phase 3 clinical trials and the stock will trade to $2
The text analyzes Cassava Sciences' simufilam, predicting its failure in Phase 3 trials for Alzheimer's disease due to ineffective mechanisms, poor pharmacokinetics, and manipulative data practices.
Oftentimes with surprisingly little liquidity, prediction markets prove highly accurate and robust in the face of interference. The "wisdom of crowds" phenomenon ensures that these markets frequently outperform traditional forecasting tools like polls. For instance, the University of Iowa operates the Iowa Electronic Markets (IEM) as a research... See more